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Abstract
Inhibition by cardiac glycosides of Na + , K + -ATPase reduces sodium efflux from myocytes and may lead to Na + and Ca 2+ overload and detrimental effects on mechanical function, energy metabolism, and electrical activity. We hypothesized that inhibition of sodium persistent inward current (late I Na ) would reduce ouabain's effect to cause cellular Na + loading and its detrimental metabolic (decrease of ATP) and functional (arrhythmias, contracture) effects. Therefore, we determined effects of ouabain on concentrations of Na + i
and high-energy phosphates using 23 Na and 31 P NMR, the amplitude of late I Na using the whole-cell patch-clamp technique, and contractility and electrical activity of guinea pig isolated hearts, papillary muscles, and ventricular myocytes in the absence and presence of inhibitors of late I Na . Ouabain (1-1.3 µM) increased Na + i and late I Na of guinea pig isolated hearts and myocytes by 3.7-and 4.2-fold, respectively. The late I Na inhibitors ranolazine and tetrodotoxin significantly reduced ouabain-stimulated increases in Na + i and late I Na .
Reductions of ATP and phosphocreatine contents and increased diastolic tension in ouabain-treated hearts were also markedly attenuated by ranolazine. Furthermore, the ouabain-induced increase of late I Na was also attenuated by the CaMKII inhibitors and AIP, but not by . We conclude that ouabain-induced Na + and Ca 2+ overload is ameliorated by inhibition of late I Na .
Introduction
Cardiac glycosides inhibit the sarcolemmal Na + , K + -ATPase (sodium pump) and increase intracellular sodium concentration ([Na + ] i ). The effect of a glycoside to increase [Na + ] i may lead to an increase of calcium influx via sodium/calcium exchange (NCX), and an increase in cardiac contractility. However, whereas a small increase of [Na + ] i may lead to a positive inotropic effect (Bers et al., 2003) , a larger increase may lead to arrhythmias and contractile dysfunction. We hypothesized that reduction of Na + entry in the presence of the cardiac glycoside ouabain would reduce sodium overloading and its adverse mechanical, metabolic, and electrical consequences. A novel approach to reduce Na + entry is by reduction of persistent Na + inward current (late I Na ) (Ver Donck et al. 1993; Hale et al. 2008) .
Late I Na is caused by entry of Na + ions through myocyte Na + channels that fail to inactivate normally. These channels stay open or re-open during the action potential plateau, when "normal" Na + channels are inactivated, thereby contributing to intracellular Na + loading (Undrovinas and Maltsev, 2008; Makielski and Farley, 2006 ). An increase of late I Na due to impaired Na + channel inactivation is common in inherited (e.g., SCN5A
mutations; Ruan et al., 2009 ) and acquired (e.g., ischemia, heart failure, remodeling, and oxidative states) pathological conditions (for review see Hale et al., 2008; Undrovinas and Maltsev, 2008) . Although small in amplitude relative to peak I Na , late I Na persists throughout the duration of the cardiac action potential and contributes significantly to Na + entry in myocytes (Makielski and Farley, 2006) . The increase of Na + entry due to an enhanced late I Na may lead to an increase of [Na + ] i . Using a computational model, Noble (2008) found that reduction of late I Na attenuated the rise of Na and leads to Ca 2+ loading of myocardial cells (Bers, 2001; Imahashi et al., 2005) . Thus, inhibition of late I Na is cardioprotective (Hale et al., 2008; Makielski and Farley, 2006; Sossalla et al., 2008) .
Reduction of late I Na can be achieved using either ranolazine or tetrodotoxin (TTX).
The antianginal drug ranolazine is a relatively selective late I Na inhibitor (Antzelevitch et al., 2004; Hale et al., 2008) . Ranolazine reduces late I Na with an approximate IC 50 value of 6.5 µM (vs. an IC 50 value of 244 µM for inhibition of peak I Na ) and causes minimal or no inhibition of L-type Ca 2+ channel current, NCX, or sodium proton exchange at therapeutic concentrations (≤ 10μM) (Antzelevitch et al., 2004; Hale et al., 2008) . In recent studies it has been shown that ranolazine reduces sea anemone toxin-II (ATX-II)-and H 2 O 2 -induced late I Na in guinea pig and rabbit isolated ventricular myocytes, and suppresses early and delayed afterdepolarizations and arrhythmic activity (Song et al., 2008; Song et al., 2004) .
Ranolazine attenuates diastolic dysfunction in myocardium isolated from failing human hearts (Sossalla et al., 2008) , in ATX-II-treated and ischemic/reperfused rat hearts (Fraser et al., 2006) , and in guinea pig hearts exposed to the ischemic metabolite palmitoyl -Lcarnitine (Wu, Y. et al., 2009) . The limitation of ranolazine is that its selectivity for inhibition of late I Na relative to hERG K + current is only 2-fold (Hale et al., 2008) . In contrast, TTX is very selective for Na + channels relative to other ion channels, but has less selectivity for late relative to peak I Na than does ranolazine. Both inhibitors were therefore used in this study to test the hypothesis that a reduction of endogenous late I Na will reduce effects of ouabain to cause cellular Na + loading, and metabolic and contractile dysfunction.
It also has been reported that a rise in intracellular Ca 2+ and phosphorylation of the cardiac Na + channel by Ca 2+ -calmodulin-dependent kinase II (CaMKII) can alter Na + channel
This article has not been copyedited and formatted. The final version may differ from this version. (Hale et al., 2008; Maier and Bers, 2007; Maltsev et al., 2008; Song et al., 2008; Undrovinas and Maltsev, 2008; Xie et al., 2009 Ranolazine is a relatively selective late I Na inhibitor. The ranolazine concentrations used in this study (3, 5, and 10 μ M) are in the mid to high therapeutic range and are known to significantly reduce the late I Na (Antzelevitch et al., 2004; Hale et al., 2008 
Results
Changes in Contractile Function of the Isolated Heart during Ouabain-Induced
Sodium Pump Inhibition in the Absence and Presence of Ranolazine or TTX.
Exposure to 0.75 μ M ouabain for 60 min led to a transient increase of left ventricular systolic pressure (LVSP) by 55 ± 5% (n = 13), followed by arrhythmic activity and by episodes of cardiac standstill (i.e., absence of a contractile response during continuous electrical pacing at 5 Hz) alternating with periods of rhythmic contraction in 11 out of 13 hearts tested (Fig. 1A) . A marked elevation of LV end diastolic pressure (LVEDP) and a decrease of developed pressure (LVDevP) were observed (Fig. 1A) . The late I Na inhibitors ranolazine and TTX reduced the occurrence of episodes of cardiac standstill and the rise of LVEDP caused by ouabain. Of eight hearts treated with 0.75 μ M ouabain +3 μ M ranolazine, four hearts showed episodes of cardiac standstill including elevated LVEDP (Fig. 1B) whereas the remaining four hearts maintained enhanced but irregular contraction.
This article has not been copyedited and formatted. The final version may differ from this version. The responses of hearts that were exposed to ouabain in the presence of 0.5 μ M TTX were comparable to those exposed to ouabain in the presence of 3 μ M ranolazine. When the (Table 1 ). Hearts exposed to ouabain in the presence of 3, 5 or 10 μ M ranolazine or 1 μ M TTX also showed better recovery of contractile function (higher developed pressure) after drug washout than hearts treated with ouabain alone (Fig. 1 ). The effects of drug treatment on values of contractile parameters are summarized in Table 1 .
Changes in Contractile Function in Papillary Muscle Preparations during Ouabaininduced Sodium Pump Inhibition in the Absence and Presence of Ranolazine.
Contractile function of the guinea pig papillary muscle was measured to confirm results of This article has not been copyedited and formatted. The final version may differ from this version. experiments performed using the isolated heart. A concentration of 2 μ M ouabain increased developed tension of papillary muscles by almost 4-fold after 20 min, from 35.4 ± 7.7 (n = 8) to 133.9 ± 37.0 mg ( Fig. 2A, C) . The developed tension of papillary muscles declined with time during a 60-min exposure to ouabain, and episodes of tachyarrhythmia were often observed ( Fig. 2A, C) . Diastolic tension of papillary muscle strips also increased significantly by 15% after a 1-hr ouabain treatment ( Upon exposure of the heart to 1.3μM ouabain, [Na + ] i increased rapidly by 3.7-fold at 60 min to reach a plateau level of 25.1 ± 1.2 mM (n = 9, p<0.001 vs. control; 3.7 ± 0.3 to 4.8 ± 0.2 mM, in hearts exposed to ouabain in the presence of ranolazine (p>0.05 versus control). Ranolazine (10 μ M, Fig. 4A ) also attenuated the ouabain-induced decrease of pH i (7.13 ± 0.01 vs. 7.07 ± 0.01, p<0.05). In summary, inhibition of late I Na effectively prevented or reduced the ouabain-induced decreases in high-energy phosphates and pH i and the increase in [Pi] .
Ouabain-Induced Late I Na . To determine if ouabain has an effect on sodium channels we measured the amplitude of late I Na in guinea pig isolated ventricular myocytes exposed to ouabain in the absence and presence of ranolazine. The amplitude of late I Na was increased by exposure of cells to ouabain (1 µM). After a 3 to 5-min exposure of myocytes to ouabain, the integrated late I Na was increased by 4.2-fold from 23.5 ± 4.9 to 99.6 ± 15.2 pC/pF (n = 8, p<0.001; Fig. 5A -C). Ranolazine (10 µM) applied to cells in the continuous presence of ouabain reduced late I Na by 69 ± 9%, from 99.6 ± 15.2 to 50.6 ± 13.6 pC/pF (n = 8, p<0.001; Fig. 5A , C). In some experiments, after washout of ranolazine, cells were exposed to TTX (3 µM, n = 6, Fig. 2B ). Ouabain-induced late current was completely inhibited by 3 µM TTX, to 21.2 ± 7.9 pC/pF (p<0.001), indicating that this current was a Na + channel current (e.g., Na V 1.5).
The ouabain-induced increase of intracellular Na + may lead to Ca 2+ uptake and activation of CaMKII. To examine the hypothesis that a Ca 2+ -dependent, CaMKII-mediated mechanism may underlie the effect of ouabain to increase late I Na , cells were incubated with ouabain when either the CaMKII inhibitor KN-93 (10 µM) or the Ca 2+ chelator EGTA
(1 mM) was dialyzed into them by inclusion in the patch pipette solution. KN-92 (10 µM),
This article has not been copyedited and formatted. The final version may differ from this version. Ouabain alone (1 µM, n = 6) caused a time-dependent increase of late I Na by 318 ± 74% from 21 ± 2 to 84 ± 12 pC/pF (p=0.003) in 5-10 min (Fig. 6A-6C ). In comparison, at the end of a 10-min exposure to ouabain in the presence of intracellular KN-93, late I Na was increased by only 76 ± 35% (from 21 ± 2 to 33 ± 6 pC/pF; n = 7, p= 0.003 vs. ouabain alone). In contrast, in the presence of the inactive analog KN-92, late I Na at the end of a 10-min exposure to ouabain was increased by 273 ± 39% (from 20 ± 1 to 72 ± 7 pC/pF; n = 6, p>0.05 vs. ouabain alone, and P<0.01 vs. . The intracellular application of 1 mM EGTA (a Ca 2+ -chelating agent) via the patch pipette prior to a 10-min exposure of isolated myocytes to ouabain also attenuated the ouabain-induced increase of late I Na : late I Na increased by only 33 ± 28% (from 23 ± 3 to 31 ± 8 pC/pF; n = 6, p<0.001 vs. ouabain alone; Fig. 6D The finding that not only late I Na inhibitors but also CaMKII inhibitors reduced ouabaininduced late I Na in myocytes suggested that CaMKII inhibitors may also improve function in the isolated guinea pig heart exposed to ouabain. KN-93 (1.8 μ M) alone decreased LVSP by 24 ± 1.1 % (p<0.03, n = 5), whereas AIP (0.3 μ M, n = 2) alone had no measurable effect This article has not been copyedited and formatted. The final version may differ from this version. and 98 ± 10, 89 ± 12, and 106 ± 11% of control in the presence of AIP (0.03, 0.3, 0.8 μ M, respectively).
Discussion
The results presented here suggest that a reduction of late I Na attenuates sodium accumulation and metabolic, contractile, and electrical dysfunction induced by the cardiac glycoside ouabain in the guinea pig isolated perfused heart and papillary muscle. (Fig. 3B,D) . This finding suggests that physiological late I Na is either a small contributor to sodium entry in the beating isolated heart, or that a decrease of caused by ouabain (Fig. 1D) , suggesting that an enhancement of persistent Na + current (late I Na ) by ouabain (Fig. 5) , was a factor contributing to the increase of [Na
This article has not been copyedited and formatted. The final version may differ from this version. in the presence of ouabain (Fig. 5, 6 ) and attenuated the ouabain-induced increase of [Na + ] i (Fig. 3) In summary our results show that ouabain stimulated an increase of late I Na in guinea pig myocytes, and direct and indirect inhibition of late I Na attenuated the ouabain-induced Na + overload and metabolic, electrical, and mechanical dysfunction in the guinea pig isolated heart and papillary muscle. The effects of an enhanced late I Na to cause Ca 2+ overload and both electrical and mechanical dysfunction of the heart suggest that late I Na has a key pathophysiological role in the heart. Therefore, inhibition of late I Na in the diseased heart and during digitalis therapy may be of clinical relevance.
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